Trial Profile
Prospective study investigating the safety, tolerability, pharmacokinetics and pharmacodynamics of Evacetrapib in healthy adults
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Dec 2015
Price :
$35
*
At a glance
- Drugs Evacetrapib (Primary)
- Indications Hypercholesterolaemia; Hyperlipidaemia
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 07 Dec 2015 New trial record